Byakangelicin is utilized in biochemical research to investigate its anti-inflammatory and antioxidant effects. It exhibits potential in suppressing the production of inflammatory cytokines such as TNF-α and IL-6, positioning it as a candidate lead compound for developing treatments for chronic inflammatory conditions, including arthritis and type 2 diabetes. Furthermore, research highlights its role in promoting glutathione synthesis, which bolsters the cellular antioxidant defense mechanism and may protect against oxidative stress-induced cellular damage. In traditional medicine, it is employed for its anti-inflammatory and analgesic properties, with emerging evidence of its ability to inhibit tumor cell growth, attracting interest in cancer research. It is also examined for enhancing blood circulation and managing cardiovascular disorders. Present in various herbal extracts, it enhances the therapeutic efficacy of these plant-based formulations.